Addressing Limitations in Hashimoto’s Thyroiditis Treatment
Hashimoto’s thyroiditis remains among the most common autoimmune endocrine disorders, yet therapeutic approaches have traditionally concentrated on controlling symptoms rather than halting disease progression. Contemporary treatment methods, dominated by levothyroxine administration, effectively compensate for hormonal deficits but fail to counteract the underlying autoimmune assault on thyroid tissue. This therapeutic shortfall highlights a significant clinical void,…